(MedPage Today) -- Guiding HIV therapy by monitoring the immune system is more cost effective than keeping an eye on viral loads, researchers reported.
hiv therapyImmune Test Better Buy than Viral Load to Guide HIV Tx (CME/CE)MedPage Today Infectious Disease Sun, 12/04/2011 - 08:00
Benefit of Early HIV Therapy Questioned (CME/CE)MedPage Today Infectious Disease Mon, 09/26/2011 - 14:00
(MedPage Today) -- Starting HIV therapy when a patient's immune system is still strong does not reduce the risk of AIDS or death, an international cohort study showed. HIV Therapy Dramatically Cuts Transmission in Heterosexual PairsMedPage Today Infectious Disease Thu, 05/12/2011 - 11:45
(MedPage Today) -- Triple-drug therapy reduced transmission of HIV by 96% in heterosexual couples when one partner is infected and the other is not, results of a randomized trial showed. Earlier HIV therapy protects against virus spreadHeadlines from the Associated Press Thu, 05/12/2011 - 11:09
WASHINGTON (AP) -- A major study finds that treating HIV patients early, before they're too sick, dramatically lowers their chances of spreading the AIDS virus to a sexual partner.... Earlier HIV therapy protects against virus spreadSeattle Post-Intelligencer: Health and Fitness Thu, 05/12/2011 - 10:12
Share: CROI: Five-Drug HIV Therapy No Better than Standard (CME/CE, wit...MedPage Today Infectious Disease Thu, 03/03/2011 - 08:30
BOSTON (MedPage Today) -- In a disappointing result, intensified antiretroviral therapy for acute and early HIV had no effect, a researcher said here. Tags:
Biomarkers could predict death in AIDS patients with severe infl...EurekAlert! - Infectious and Emerging Diseases Mon, 12/20/2010 - 23:00
(Public Library of Science) A study in this week's PLoS Medicine suggests that AIDS patients with cryptococcal meningitis who start HIV therapy are predisposed to immune reconstitution inflammatory syndrome -- an exaggerated inflammatory immune response that kills up to one-third of affected people -- if they have biomarkers (biochemicals) in their blood showing evidence of a damaged immune system that is not capable of clearing the fungal infection. Tags:
Preventive HIV Therapy May Limit Later Response (CME/CE)MedPage Today Infectious Disease Wed, 10/13/2010 - 15:00
(MedPage Today) -- Most HIV-positive women and children exposed to nevirapine (Viramune) during the peripartum period can go on to use the drug later, but a sizable minority will not respond to it, two studies showed. Intensified HIV Therapy Fails to Eradicate Virus (CME/CE)MedPage Today Infectious Disease Tue, 08/10/2010 - 15:00
(MedPage Today) -- In patients whose HIV is already well-controlled, intensifying the therapy has no apparent effect on residual viremia, researchers said. NIH-funded study finds early HAART during TB treatment boosts su...EurekAlert! - Infectious and Emerging Diseases Wed, 07/21/2010 - 22:00
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. Tags:
|
